Literature DB >> 12654954

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.

K Seppi1, M F H Schocke, R Esterhammer, C Kremser, C Brenneis, J Mueller, S Boesch, W Jaschke, W Poewe, G K Wenning.   

Abstract

BACKGROUND AND
OBJECTIVE: The parkinson variant of multiple system atrophy (MSA-P) and progressive supranuclear palsy (PSP) present with atypical parkinsonism, which may be misdiagnosed as PD, particularly in early disease stages. It was previously shown that diffusion-weighted MRI (DWI) is a sensitive tool to discriminate MSA-P from PD based on increased apparent diffusion coefficients (ADCs) in the putamen. In this study DWI was evaluated in 10 patients with PSP compared with 13 patients with PD and 12 with MSA-P.
METHODS: Disease was diagnosed according to established diagnostic criteria and groups were matched for age, disease duration, and Hoehn and Yahr "off" stage. Regional ADCs (rADCs) were determined in different brain regions including basal ganglia, gray matter, white matter, substantia nigra, and pons.
RESULTS: In patients with PSP compared with those with PD, rADCs were significantly increased in putamen, globus pallidus, and caudate nucleus. Stepwise logistic regression analysis followed by receiver operating characteristics analysis identified an optimal cut-off value for putaminal rADC, discriminating PSP and PD with a sensitivity of 90% and a positive predictive value of 100%. DWI failed to discriminate PSP and MSA-P.
CONCLUSIONS: These results show that DWI detects basal ganglia abnormalities in PSP patients within few years of disease onset, discriminating patients with PSP from those with PD, but not from those with MSA-P.

Entities:  

Mesh:

Year:  2003        PMID: 12654954     DOI: 10.1212/01.wnl.0000049911.91657.9d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  58 in total

1.  Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging.

Authors:  Masato Kanazawa; Takayoshi Shimohata; Kenshi Terajima; Osamu Onodera; Keiko Tanaka; Shoji Tsuji; Kouichirou Okamoto; Masatoyo Nishizawa
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging.

Authors:  Kazumichi Tsukamoto; Eiji Matsusue; Yoshiko Kanasaki; Suguru Kakite; Shinya Fujii; Toshio Kaminou; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2012-01-25       Impact factor: 2.804

3.  Magnetic resonance imaging in progressive supranuclear palsy.

Authors:  M Stamelou; S Knake; W H Oertel; G U Höglinger
Journal:  J Neurol       Date:  2010-12-22       Impact factor: 4.849

Review 4.  How to diagnose MSA early: the role of magnetic resonance imaging.

Authors:  K Seppi; M F H Schocke; G K Wenning; W Poewe
Journal:  J Neural Transm (Vienna)       Date:  2005-07-06       Impact factor: 3.575

Review 5.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

6.  Tracking the neurodegeneration of parkinsonian disorders--a pilot study.

Authors:  C Nilsson; K Markenroth Bloch; S Brockstedt; J Lätt; H Widner; E-M Larsson
Journal:  Neuroradiology       Date:  2007-01-03       Impact factor: 2.804

Review 7.  Neuroimaging in Parkinson's disease.

Authors:  David J Brooks
Journal:  NeuroRx       Date:  2004-04

8.  Magnetic resonance imaging in spinocerebellar ataxias.

Authors:  Susanne Döhlinger; Till-Karsten Hauser; Johannes Borkert; Andreas R Luft; Jörg B Schulz
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Altered diffusion in the frontal lobe in Parkinson disease.

Authors:  A T Karagulle Kendi; S Lehericy; M Luciana; K Ugurbil; P Tuite
Journal:  AJNR Am J Neuroradiol       Date:  2008-01-17       Impact factor: 3.825

10.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.